Fig. 1From: Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy systemOverall survival rates in all patients (a), patients with stage IA and with stage IB + IIA (b), respectivelyBack to article page